ALBION FINANCIAL GROUP /UT - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 68 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
ALBION FINANCIAL GROUP /UT ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$20,000
+25.0%
23,8000.0%0.00%
+50.0%
Q2 2019$16,000
-20.0%
23,8000.0%0.00%
-33.3%
Q1 2019$20,000
-47.4%
23,8000.0%0.00%
-50.0%
Q4 2018$38,00023,8000.01%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 2,590,673$1,399,0001.00%
Deer VI & Co. LLC 675,242$365,0000.28%
Sarissa Capital Management LP 1,700,000$917,0000.25%
NEA Management Company, LLC 10,362,694$5,596,0000.22%
Perceptive Advisors 3,108,808$1,678,0000.12%
Cormorant Asset Management, LP 1,087,715$587,0000.08%
683 Capital Management, LLC 1,000,000$540,0000.04%
Spark Investment Management LLC 95,800$51,0000.00%
Elgethun Capital Management 10,000$5,0000.00%
TWO SIGMA SECURITIES, LLC 14,738$8,0000.00%
View complete list of AVEO PHARMACEUTICALS INC shareholders